Search results
Found 145 matches for
It's beginning to look a lot like Gutmas!
28 November 2025
Congratulations to Vy Wien Lai, whose image was chosen for 1st place in the MRC/MRF 2025 Festive Science Image Competition.
Iron supplement absorption preserved in children with HIV and boosted by prebiotics
13 November 2025
New research shows that iron from supplements and fortified foods is well-absorbed in children living with virally suppressed HIV, and that administering iron supplements with prebiotics may enhance their effectiveness and improve their safety.
Oxford scientists map the cells that drive Crohn’s disease fistulas
12 November 2025
Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn’s disease - paving the way for targeted treatments.
Unravelling T-Cell Recognition: Insights from Immunology and AI
13 October 2025
From 29 September to 1 October 2025, researchers from across the world gathered in Oxford for a unique conference and hackathon exploring how advances in artificial intelligence can deepen understanding of T-cell biology.
New study links cancer stage to strength of antitumoral immune response in HR+ breast cancer
29 July 2025
The latest study from researchers in the MRC Translational Immune Discovery Unit in the MRC Weatherall Institute of Molecular Medicine has been published in Cell Reports Medicine.
Thelior Bio: rethinking gut health from the inside out
10 July 2025
A new spinout company, formed from research conducted at the MRC Translational Immune Discovery Unit, aims to develop a new class of therapies for patients with inflammatory bowel disease.
Study identifies key immune structures in the gut that may drive coeliac disease
6 May 2025
Researchers in Oxford have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease and could provide a target for future therapies.
Wellcome Career Development Award For Agne Antanaviciute
2 April 2025
Dr Agne Antanaviciute has won a Wellcome Career Development Award for her research investigating early-life immunity.
New study reveals details of key immune mechanism
25 March 2025
An international collaboration, initiated by the Jackson Group at the MRC Weatherall Institute of Molecular Medicine, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.
Ancient genomic linkage regulates red blood cell development
24 March 2025
A collaboration between the Drakesmith and Higgs Groups at the MRC Weatherall Institute of Molecular Medicine has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.
Cancer Cell study identifies possible ways cancer treatment can lead to harmful side effects
16 May 2024
Researchers from the Simmons and Koohy Groups in the Weatherall Institute of Molecular Medicine (WIMM) Translational Immune Discovery Unit have identified potential pathways by which cancer treatment can cause colitis.
Professor Graham Ogg Receives Wellcome Discovery Award with International Team
16 April 2024
Professor Graham Ogg, from the MRC Weatherall Institute of Molecular Medicine has been awarded funding for an international 8-year research programme from global charitable foundation Wellcome.
Emeritus Professor David Jackson receives Lifetime Achievement Awards
19 October 2023
Professor David Jackson has been awarded the Rooster Prize by the International Society for Hyaluronan Sciences (ISHAS) and the Gasparo Aselli Medal by the International Society of Lymphology (ISL).
Professor Simon Davis appointed as RDM’s first Entrepreneurship Lead
5 October 2023
Simon Davis, Professor of Molecular Immunology in the MRC TIDU at the MRC WIMM, has been appointed as RDM’s first Entrepreneurship Lead.